Mylan agrees to pay $30M in SEC EpiPen settlement

Mylan agrees to pay $30M in SEC EpiPen settlement

Mylan will pay $30 million to settle US charges it misled investors about probes of EpiPen payments under a federal health program, a US securities regulator announced Friday. Mylan settled the case without admitting or denying the allegations. The charges concern...